newsfilter
← Latest News
Earnings Call Transcripts·

Boeing 3Q 2026 Earnings Call - AVIALL INC

  • Explicit Guidance:

    • Free Cash Flow (FCF):
      • 2026: ~$2 billion (includes ~$700M DOJ settlement payment avoidance in 2027, KC-46A Lot 13 advance, and seasonal working capital benefits).
      • 2027: ~$3 billion (inclusive of ~$1B increase in CapEx for BDS growth and absence of 2026 DOJ payment; assumes 777X certification by mid-2027).
      • 2028: ~$6 billion (driven by improved cash margins on 737/787, positive cash contribution from 777X, and abatement of legacy cash drags).
      • 2029: ~$10 billion (normalized target; assumes higher production levels: 52+ rate on 737, 10+ rate on 787, and positive FCF from 777X).
      • 2030+: Significant growth potential exceeding $10 billion.
    • Capital Expenditure (CapEx):
      • 2027: ~$5 billion (approx. $1B higher than 2024).
      • 2028–2029: ~$4 billion annually.
      • Long-term normalized target: ~3–4% of revenue.
    • Production Deliveries (BCA):
      • 2027 Total: Expects 10%+ increase vs. prior year; specific program mix (737/787/777X) to be clarified in January.
      • 2027 Volume: 737 deliveries expected to be shy of 500 due to stability delays; 787 deliveries expected in the 90–100 range (lower end of guidance) due to 787 rate delays.
      • 2027 Inventory Liquidation: Expect delivery of ~30 pre-built 737-7 and 737-10 aircraft.
      • 2029 Assumptions (for FCF modeling): 737 delivery rate in mid-to-high 50s; 787 at ~12/month; 777X generating positive FCF.
    • Margins:
      • BCA (Commercial): Expected to reach break-even margins in early 2028; 737 margins will not reach 2018 levels, while 787 margins will exceed 2018 levels by 2029.
      • BDS (Defense): Path to high single-digit operating margins by end of decade; achieved 6.2% in Q3 with gains on HRL sale.
      • BGS (Services): Sustained double-digit margins on commercial and government businesses.
  • Business-Segment Outlook:

    • 737 Program:
      • Target production rate of 52 per month in the back half of 2027; stabilization at 47/month expected to extend into 2027 to ensure supply chain resilience.
      • Wing production stability is the primary bottleneck; back shops and Wichita fuselage integration must be synchronized.
      • 737-7 and 737-10 certifications completed; deliveries to begin early next year.
    • 787 Program:
      • Stable at 8/month; transition to 10/month expected later this year, constrained by engine delivery performance ( pacing item).
      • Charleston expansion underway; majority of new capacity (third final assembly line) coming online late 2027.
      • 2027 deliveries expected closer to 90 than 100 due to rate delays.
    • 777X Program:
      • First delivery expected in 2027 (based on mid-year certification assumption); production rate of ~1/month for most of 2027.
      • Significant cash use expected in 2027, improving in 2028, turning positive in 2029.
      • Financial plan includes management reserves for potential certification delays to mid-2027 without breaching EAC.
    • Defense & Space (BDS):
      • FAXX Program: Selected to design, build, and deliver the sixth-generation fighter for U.S. Navy (F47 selected for USAF); revenue not in Q3 backlog pending contract finalization.
      • PAC-3 Seeker: Secured seven-year contract to triple production.
      • F-15EX: Received contract for 22 units (120 total under contract); potential for additional upside.
      • Starliner: Path to support future flights established with $359M additional NASA funding; reduced program risk.
      • Margin Outlook: Expecting steady margin improvement; high single-digit margins by 2030.
    • Global Services (BGS):
      • Revenue up 11% (ex-cl divestiture) driven by government and commercial modifications; backlog of $33B with $5B orders in quarter.
      • C-17 heavy maintenance program performing at record low rework levels with expanded scope.
  • Market and Competitive Outlook:

    • Backlog: Record backlog of $745B (BCA backlog $612B; BDS backlog $101B; BGS backlog $33B).
    • Demand Dynamics:
      • High fuel prices driving demand for replacement aircraft (new generation efficiency) rather than suppressing orders; no customers reported replanning growth orders.
      • BCA booking rates facing pressure from production rate adjustments but supported by robust pipeline.
      • BDS sector identified as a "sleeper" with expected growth shifting from low single-digits to middle single-digits or higher.
    • Pricing: Improved pricing dynamics reflected in record backlog; fixed-price development contracts underwritten with appropriate risk mitigation.
  • Macro / Industry Outlook:

    • Oil Prices: Management anticipates airlines passing higher fuel costs to ticket prices; views high fuel prices as a catalyst for new aircraft replacement orders.
    • Supply Chain: No systemic challenges identified; focus on stabilizing wing and fuselage production flows.
    • Regulatory Environment: Post-ACSA regulatory framework better understood following 737-7/10 certification; enabling more efficient certification paths for 777X.
    • Tax/Interest: No significant cash tax payments expected until early 2030s; interest cash outflows expected to decline slightly with maturities.
  • Strategic Initiatives:

    • Capacity Expansion:
      • Charleston (787): Third final assembly line adding capacity/flexibility; major capability online late 2027.
      • Northline (737): Must be certified and producing to support rate 52.
      • Wichita (737): Implementing safety/quality plans; fuselage production ramping up to synchronize with final assembly at rate 52.
    • New Product Development:
      • Team actively defining new single-aisle aircraft; no change in outlook regarding market timing.
      • Investment shift expected from 737/777 program R&D to new programs upon completion.
    • M&A/Divestitures: Completed divestiture of Digital Aviation Solutions (impacted BGS revenue comparison); strategic sale of HRL Laboratories contributed to BDS Q3 margin gain.
  • Risks and Headwinds to Outlook:

    • Production Stability: 737 rate 52 ramp delayed to late 2027 due to wing production yields and back-shop flow issues; fuselage synchronization remains a watch item.
    • Certification Timing: 777X certification remains a key risk; a slip to mid-2027 is financially provisioned for but would impact delivery timing.
    • Abnormal Costs: Disruption from wing component supplier (GKN windows context implied) causing production gaps in 777 freighter/767 tanker lines; costs treated as abnormal expenses over next few quarters.
    • Legacy Cash Drags: Negative cash flow impacts from legacy programs expected to abate by 2029 but remain a factor in 2027–2028 trajectory.
    • Working Capital: Potential for lower year-over-year BCA order deposits and unfavorable working capital in 2027.
    • Macro Sensitivity: Potential for softening demand in "growth market" (new vs. replacement) if high fuel prices persist, though backlog offers protection.
  • Management Tone on the Future:

    • Confidence Level: High confidence in delivering multi-year FCF targets ($10B by 2029) due to narrowed range of outcomes and reduced portfolio risk.
    • Strategic Shift: Moving from "restoring trust" to "meeting higher expectations"; emphasizing discipline and safety over speed in production ramps.
    • Outlook Revision: Significant narrowing of previous ranges; management explicitly states the bar is higher and expectations for durability are rising.
    • Hedges: Cautious on 737 ramp speed ("more important to do it right than specific month"); 777X guidance includes management reserves for delay scenarios.
  • Miscellaneous:

    • Tax Rate: No specific effective tax rate provided; cash tax payments deferred until early 2030s.
    • Share Count/Dividends: No specific guidance on buybacks or dividends mentioned in the forward-looking segments; focus remains on balance sheet strengthening and investment grade rating.
    • Cost Structure: Normalized CapEx expected to settle at 3–4% of revenue (higher than historical 2%); R&D costs shifting from program-specific to general tech development.
Company
AVIALL INC
Keywords
AVIALL INC